IP Library Granted Patent US 7,947,727
Granted Patent B2
US 7,947,727 · App. 12/444,713 · Granted May 24, 2011

Compounds

Assignee: GlaxoGroupLimited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,947,727
App. No.
12/444,713
Granted
May 24, 2011
Kind
B2
Abstract

The present invention provides compounds of formula (I): a process for their preparation, pharmaceutical compositions comprising the compounds and the preparation of said compositions, intermediates and use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation, allergy and/or skin disease.

Claims (19)

1. A compound of formula (I):

wherein

R 1 is thienyl or

R 2 is ethyl or n-propyl;

R 3 is hydrogen or methyl;

R 4 is hydrogen or fluorine;

R 5 and R 6 are each independently hydrogen, methyl, fluorine, chlorine or trifluoromethyl; or a salt thereof.

2. A compound according to claim 1 wherein R 1 is

3. A compound according to claim 1 wherein R 2 is ethyl.

4. A compound according to claim 1 wherein R 3 is hydrogen.

5. A compound according to claim 1 wherein R 4 is fluorine.

6. A compound according to claim 1 wherein R 5 is hydrogen and R 6 is methyl, fluorine or chlorine.

7. A compound according to claim 1 wherein R 5 and R 6 are both fluorine or both chlorine.

8. A compound which is selected from the group consisting of:

N-ethyl-2-methyl-N-[3,3,3-trifluoro-2-({[1-(4-fluorophenyl)-1H-indazol-4-yl]amino}methyl)-2-hydroxypropyl]benzamide;

N-ethyl-2-fluoro-N-[3,3,3-trifluoro-2-({[1-(4-fluorophenyl)-1H-indazol-4-yl]amino}methyl)-2-hydroxypropyl]benzamide;

2,6-dichloro-N-ethyl-N-[3,3,3-trifluoro-2-({[1-(4-fluorophenyl)-1H-indazol-4-yl]amino}methyl)-2-hydroxypropyl]benzamide; and a salt thereof.

9. A method of treating an inflammatory and/or allergic condition in a human or animal subject in need thereof, which method comprises administering to said human or animal subject an effective amount of a compound as claimed in claim 1 , or a pharmaceutically acceptable salt thereof.

10. A method of treating rheumatoid arthritis, asthma, COPD, allergy and/or rhinitis in a human or animal subject in need thereof, which method comprises administering to said human or animal subject an effective amount of a compound as claimed in claim 1 , or a pharmaceutically acceptable salt thereof.

Assignments (2)
CHANGE OF ADDRESS Recorded Apr 16, 2025
From: GLAXO GROUP LIMITED
To: GLAXO GROUP LIMITED
Reel/Frame 071044/0904 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2009
From: BIGGADIKE, KEITH; COOPER, ANTHONY WILLIAM JAMES; HOUSE, DAVID; MACDONALD, SIMON JOHN FAWCETT; SKONE, PHILIP ALAN; WEINGARTEN, GORDON GAD
To: GLAXO GROUP LIMITED
Reel/Frame 022602/0957 →
Priority Claims (1)
GB 0620385.5 · Oct 13, 2006 · national
Continuity (1)
Related Publication 20100120883A1 · May 13, 2010